COLUMBIA BIOMEDICAL TECHNOLOGY ACCELERATOR
A major goal of the program is to educate researchers, clinicians, and students about the many aspects involved in commercializing biomedical innovation.
2018 Biomedx bootcamp
News and Events
Now in its seventh year, BiomedX has received over 140 applications and funded 47 teams for $4.3M cumulatively. Of those 47 teams, 19 have been licensed to startups or industry. Collectively, the 47 funded teams have generated $70M in follow-on funding or professional investment.
This year 18 teams were selected to participate in the BiomedX bootcamp focused on commercializing medical technologies. The course included 34 principal investigators (engineering, life sciences, clinical) and 23 graduate students (engineering, MBA, MD, DMD) enrolled for credit and embedded on the project teams. A subset of teams participating in the course were selected to pitch their envisioned technologies and business opportunities for potential commercialization support through the BiomedX program on April 24th, 2018.